Sleep Apnea Device Market Set to Hit USD 17.4 Billion by 2033, Riding on a Strong 7.2% CAGR | Market.us
05 févr. 2024 04h06 HE
|
Market.Us
New York, Feb. 05, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Global Sleep Apnea Device market size is forecasted to exceed USD 17.4 Billion by 2033, with a promising CAGR of 7.2% from...
Metered Dose Inhalers Market Forecast a Steady Growth at 4.9% CAGR, Projected to Hit US$39.4 Billion by 2030 | Persistence Market Research
23 janv. 2024 03h45 HE
|
Persistence Market Research
New York, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Metered Dose Inhalers Market Overview: The metered dose inhalers (MDIs) market has witnessed substantial growth and innovation in recent years, driven...
Ultrasonic Nebulizers Market to Exceed USD 325.6 million by 2031, Expanding at a CAGR of 5.4% | Exclusive Report by Transparency Market Research
21 août 2023 05h53 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global ultrasonic nebulizers market is projected to flourish at a CAGR of 5.4% from...
Stethoscope Market Size to Hit USD 991.6 Mn by 2032 Due to Rising Cardiovascular & Respiratory Disorders | TMR Study
19 avr. 2023 10h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, April 19, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research, the global Stethoscope Market is anticipated to grow at a 6% CAGR from 2023 to...
CPAP Devices Market Size is projected to reach USD 5254.51 million by 2030, growing at a CAGR of 7.4%: Straits Research
17 oct. 2022 11h50 HE
|
Straits Research
New York, United States, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Continuous positive airway pressure (CPAP) devices are used to treat obstructive sleep apnea disorder. The device increases the air...
Peptide Therapeutics Market Expanding at an Impressive CAGR of 11% over the period of 2022 to 2025 | Future Market Insights, Inc.
06 sept. 2022 07h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The global peptide therapeutics market is projected to reach a valuation of US$ 47 Bn in 2025, with sales growing at a prolific CAGR of 11% from 2022...
Growing Demand for Artificial Respiration Systems During COVID-19 Pandemic to Boost the Growth of the Oxygen Cylinder and Concentrator Market and Portable Oxygen Kit Market by 2026 – Exclusive Report By Research Dive
26 juil. 2021 09h00 HE
|
Research Dive
New York, USA, July 26, 2021 (GLOBE NEWSWIRE) -- Latest reports on the global oxygen cylinder and concentrator market and global portable oxygen kit market have been added by Research Dive to its...
Global Respiratory Disease Testing Industry to Gain $20.1 Billion by 2027 at a CAGR of 9.2% during the Covid-19 Pandemic – Exclusive Report [227 Pages] By Research Dive
10 juin 2021 09h00 HE
|
Research Dive
New York, USA, June 10, 2021 (GLOBE NEWSWIRE) -- As per a new report studied by Research Dive, the global respiratory disease testing market is anticipated to surpass $20.1 billion revenue by 2027,...
Rare Disease Treatment Market revenue to cross USD 317 Bn by 2026: Global Market Insights, Inc.
19 nov. 2020 04h00 HE
|
Global Market Insights, Inc
Selbyville, Delaware, Nov. 19, 2020 (GLOBE NEWSWIRE) -- According to latest report “Rare Disease Treatment Market by Drug Type (Biologics, Non-biologics), Therapeutic Area (Cancer, Blood-related...
RespireRx Pharmaceuticals Inc. and Impression Healthcare Limited Announce Agreement to Explore Commercialization of Dronabinol for the Treatment of Obstructive Sleep Apnea (OSA) in Australia, New Zealand and Southeast Asia
19 févr. 2019 08h50 HE
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Feb. 19, 2019 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the research and development of cannabinoids for the...